A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NF / nonfailing

[Related PubMed/MEDLINE]
Total Number of Papers: 48
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NF  (>> Co-occurring Abbreviation)
Long Form:   nonfailing
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. DEGs, HF, ICM
2017 Connective tissue growth factor dependent collagen gene expression induced by MAS agonist AR234960 in human cardiac fibroblasts. CTGF
2017 Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy. IDC, MMP, TIMP
2017 Pediatric dilated cardiomyopathy hearts display a unique gene expression profile. DCM, LV, NRVMs, RT-PCR
2016 2-Deoxyadenosine triphosphate restores the contractile function of cardiac myofibril from adult dogs with naturally occurring dilated cardiomyopathy. dATP, DCM, kACT
2016 Differential protein expression and basal lamina remodeling in human heart failure. BL, PO
2016 Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy. DCM, DEGs
2016 Monoamine Oxidase Is Overactivated in Left and Right Ventricles from Ischemic Hearts: An Intriguing Therapeutic Target. ALDH-2, HF, MAO, ROS
2014 Dysregulation of cardiolipin biosynthesis in pediatric heart failure. IDC
10  2014 Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair. CDCs, HF, MI, SDF
11  2014 Xenograft of microencapsulated Sertoli cells for the cell therapy of type 2 diabetes mellitus in spontaneously diabetic nonhuman primates: preliminary data. FACS, GTT, MC-pSC, T2DM, VAT
12  2013 Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure. Col, CTGF, ECM, HF, ICM, LV, LVAD, MMP, TGF
13  2013 Relevance of stretch-induced phosphorylation of MAPK and p90rsk in human myocardium. MAPK
14  2013 Thymidine kinase and mtDNA depletion in human cardiomyopathy: epigenetic and translational evidence for energy starvation. DCM, LV, mtDNA, nDNA, TK1
15  2012 Impaired JAK2-induced activation of STAT3 in failing human myocytes. Ang, Bcl, ERK, FasL, JAK, MAPK
16  2011 Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium. PP
17  2011 Significance of thymosin beta4 and implication of PINCH-1-ILK-alpha-parvin (PIP) complex in human dilated cardiomyopathy. FAs, HF, ILK, MI, PIP, TAC, Tbeta4
18  2009 Transmural expression of ion channels and transporters in human nondiseased and end-stage failing hearts. HF
19  2008 Reduced effects of BAY K 8644 on L-type Ca2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation. ACh, dbcAMP, HVMs, ISO, LVAD
20  2007 Chronic treatment with carvedilol improves Ca(2+)-dependent ATP consumption in triton X-skinned fiber preparations of human myocardium. TnI
21  2006 Association of annexin A5 with Na+/Ca2+ exchanger and caveolin-3 in non-failing and failing human heart. IPs, MPs, ZW 3-14
22  2006 Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. DCM
23  2005 Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. ACE2, ICM, NICM
24  2005 Left ventricular SERCA2a gene down-regulation does not parallel ANP gene up-regulation during post-MI remodelling in rats. ANP, CHF, LV, MI, SR
25  2005 Regional differences in the force-frequency relation of human left ventricular myocardium in mitral regurgitation: implications for ventricular shape. FFR, LV, MR, MR-FW
26  2005 Role of the NF-kappaB signaling cascade and NF-kappaB-targeted genes in failing human hearts. IKK, NF-kappaB
27  2004 Cytoskeletal structure and recovery in single human cardiac myocytes. LVAD
28  2003 Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. DCM, IL-6, JAK, JAKs, LIF, LV, STATs
29  2003 Cellular basis of abnormal calcium transients of failing human ventricular myocytes. ---
30  2003 Dynamic regulation of sodium/calcium exchange function in human heart failure. AP, Ca, HF, INCX, NCX
31  2002 Alterations of myocardial dynamic stiffness implicating abnormal crossbridge function in human mitral regurgitation heart failure. FTI, LV, MR
32  2002 Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium. DCM
33  2002 Calcium sparks in human ventricular cardiomyocytes from patients with terminal heart failure. FWHM, HF, SR
34  2002 L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices. Ca,L, db-cAMP, HVMs, ISO, LTCC, LVAD, PP2A, SR
35  2002 Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. ---
36  2002 The gene expression fingerprint of human heart failure. ---
37  2001 Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Ang II, ET, HF, IGF-I, NYHA
38  1999 Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. DCM, PKA, RI, TnI
39  1998 Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. NOS III
40  1997 Human heart failure: determinants of ventricular dysfunction. DCM
41  1997 Myosin heavy chain gene expression in human heart failure. DHD, LVs, MyHC
42  1996 Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling. DCM, SR
43  1995 Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. DHD, ICYP
44  1992 Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy. DA, DBT, IDC, NE, NPY
45  1992 Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. NYHA, TPT
46  1990 Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity. ---
47  1990 Existence of a flip-flop kinetic model for zidovudine (AZT) after oral administration. AZT
48  1985 Drug absorption in spinal cord injury. ACE, RBF, SCI